Skip to main content

Table 1 Clinic location and number of dogs enrolled in two clinical field studies in the northern and southern regions of Australia

From: Efficacy and safety of sarolaner (Simparica®) in the treatment and control of naturally occurring flea infestations in dogs presented as veterinary patients in Australia

Clinic location

Primary dogs (efficacy)

All dogs (safety)

Sarolaner

(2–4 mg/kg)

Spinosad

(≥ 30 mg/kg)

Total

Sarolaner

(2–4 mg/kg)

Spinosad

(≥ 30 mg/kg)

Total

Northern study

 Atherton, QLD

5

2

7

12

3

15

 Indooroopilly, QLD

4

2

6

6

2

8

 Stratford, QLD

9

5

14

12

7

19

 Hervey Bay, QLD

12

7

19

18

8

26

 New Farm, QLD

2

1

3

4

1

5

 Kuraby, QLD

3

2

5

3

4

7

 Total

35

19

54

55

25

80

Southern study

 St Marys, NSW

2

1

3

2

1

3

 Northbridge, NSW

6

4

10

14

7

21

 Guildford, NSW

12

6

18

17

11

28

 Trafalgar, VIC

6

3

9

8

6

14

 Moorabbin, VIC

7

4

11

9

7

16

 Total

33

18

51

50

32

82